Related Experiment Video
Updated: Mar 7, 2026

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
Direct Comparison of Gamma Knife Radiosurgery and Microsurgery for Small Size Meningiomas
Shyamal C Bir1, Devi Prasad Patra1, Tanmoy Kumar Maiti1
1Department of Neurosurgery, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
Background:
Patients with small (<3 cm) intracranial meningiomas can be either observed or treated. Treatment can be either radiosurgery or microsurgery if and when tumor progression occurs. We compared local tumor growth control and recurrence-free survival (RFS) of microsurgical resection and radiosurgery in small intracranial meningiomas and identified predictors of unfavorable outcome.
Methods:
A retrospective review (2005-2016) was performed of 90 consecutive patients with intracranial meningiomas who underwent either microsurgery (n = 31) or Gamma Knife radiosurgery (GKRS) (n = 59). The study population was evaluated clinically and radiographically after treatment.
Results:
GKRS in meningiomas showed a significantly higher percentage of local control of tumor growth compared with microsurgery (P = 0.02) 5 and 10 years (P = 0.003) after treatment. The median RFS was also significantly higher in the GKRS group compared with the microsurgery group (P = 0.04). There was no difference in RFS between Simpson grade I resection and GKRS (P = 0.69). In univariate analysis, RFS after procedures was significantly affected by tumor involvement of cranial nerves, presence of comorbidities, and preoperative Karnofsky performance scale score ≤70. In multivariate analysis, only preoperative Karnofsky performance scale score ≤70 was a predictor of unfavorable outcome.
Conclusions:
GKRS offers a high rate of tumor control and longer RFS that is comparable to Simpson grade I resection. Subtotal resection is not a good choice for small meningiomas. The treatment procedure should be tailored according to the presence of comorbidities and the maximum benefit for the patient.
Insights
Gamma Knife radiosurgery (GKRS) offers superior tumor control and recurrence-free survival (RFS) for small intracranial meningiomas compared to microsurgery. Patient outcomes are influenced by comorbidities and performance status.
Area of Science:
- Neurosurgery
- Radiation Oncology
- Oncology
Background:
- Small intracranial meningiomas (<3 cm) present treatment dilemmas: observation versus intervention.
- Intervention options include microsurgery or radiosurgery, typically employed upon tumor progression.
- Predictors of unfavorable outcomes require identification for personalized treatment strategies.
Purpose of the Study:
- To compare local tumor growth control and recurrence-free survival (RFS) between microsurgical resection and Gamma Knife radiosurgery (GKRS) for small intracranial meningiomas.
- To identify predictors of unfavorable outcomes in patients treated for small intracranial meningiomas.
Main Methods:
- Retrospective review of 90 patients with intracranial meningiomas treated between 2005-2016.
- Comparison of outcomes between microsurgery (n=31) and GKRS (n=59).
- Clinical and radiographic evaluations post-treatment to assess outcomes.
Main Results:
- GKRS demonstrated significantly higher local tumor control rates at 5 and 10 years post-treatment compared to microsurgery (P=0.02 and P=0.003, respectively).
- Median recurrence-free survival (RFS) was significantly longer in the GKRS group versus the microsurgery group (P=0.04).
- No significant difference in RFS was observed between GKRS and Simpson grade I microsurgical resection (P=0.69). Preoperative Karnofsky performance scale score ≤70 was the sole predictor of unfavorable outcome in multivariate analysis.
Conclusions:
- GKRS provides high tumor control rates and extended RFS, comparable to Simpson grade I resection for small meningiomas.
- Subtotal resection is not recommended for small meningiomas due to suboptimal outcomes.
- Treatment decisions should be individualized based on patient comorbidities and overall benefit.
More Related Videos
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
08:23Implementation of Minimally Invasive Brain Tumor Resection in Rodents for High Viability Tissue Collection
Published on: May 9, 2022